Tumor Classification: It aids in understanding tumor classification and progression by monitoring gene expression and transcriptome changes.
Driver Mutations: RNA-Seq helps identify mutations that drive cancer initiation and progression, distinguishing them from passenger mutations.
Pathway Analysis: It reveals pathways that are up- or down-regulated in cancer, providing crucial information for identifying molecular targets for precision therapeutics.
Cancer Subtypes: Transcriptomic differences between cancer samples and non-cancerous tissue help differentiate cancer subtypes and assess the impact of mutations.
Intratumor Heterogeneity: RNA-Seq can investigate intratumor transcriptomic diversity, providing insights into tumor evolution and metastasis.